News

IN THE Operation Varsity Blues scandal of 2019, 50 wealthy parents were charged with trying to get their children into elite universities through fraudulent means. The story dramatically demonstrated the lengths to which some parents will go to ensure their...

The gene-editing tool CRISPR enabled a groundbreaking new treatment for sickle-cell disease, and in the future, scientists anticipate that it could be used to tackle cancer, forms of inherited blindness, various superbug infections and even HIV...

There was immediate backlash when Alabama’s Supreme Court ruled in February that embryos created through in vitro fertilization qualified as...

When venture capitalist Jack Abraham first began dating his wife, Gabriella Massamillo, he insisted on one condition: that when they...

purple cancer cells
By Michael Le Page, New Scientist | 12.11.2022

A teenager with aggressive leukaemia now has no detectable cancer cells after becoming the first person to receive a treatment...

crispr
By Fyodor Urnov, The New York Times | 12.09.2022

The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation...

He Jiankui at his panel in 2018
By Peter McKnight, Vancouver Sun | 12.08.2022

When a scientist announces the opening of a new laboratory, it doesn’t ordinarily make news around the world. But Chinese...

state capitol building
By Nick Reynolds, Newsweek | 12.07.2022

A West Virginia lawmaker is proposing legislation to stop drug offenders from having children in an effort to reduce the...

police in riot gear
By Niha Masih, The Washington Post | 12.07.2022

San Francisco’s Board of Supervisors voted Tuesday to bar police from using robots to kill, in a striking reversal that...

a dna double helix
By Anna Clark, Adriana Gallardo, Jenny Deam and Mariam Elba, ProPublica | 12.06.2022

Amanda wanted to warn someone. In June 2021, her daughter — the one she and her husband had tried for...

neuron
By Gina Kolata, The New York Times | 12.05.2022

In a bold attempt to stop the progress of some cases of Alzheimer’s disease, a group of researchers is trying...

FDA logo
By Nick Paul Taylor, Fierce Biotech | 12.05.2022

The FDA has set out its reasons for putting Verve Therapeutics’ high cholesterol gene editing therapy on hold. Officials want...